Final US hurdle for Merck's COVID-19 pill: FDA panel review

WASHINGTON (AP) — An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on the medication from drugmaker Merck. The Food and Drug Administration is asking its outside experts whether the agency should authorize the pill, [...]